Influence of gender and interleukin-10 deficiency on the inflammatory response during lung infection with Pseudomonas aeruginosa in mice

Immunology

Volumn 107, Issue 3, 2002, Pages 297-305

  Guilbault, Claudine ^a   Stotland, Peter ^a   Lachance, Claude ^a   Tam, Mifong ^a   Keller, Anna ^a   Thompson Snipes, Luann ^a   Cowley, Elizabeth ^b   Hamilton, Thomas A ^c   Eidelman, David H ^d   Stevenson, Mary M ^a   Radzioch, Danuta ^a  

^a MONTREAL GENERAL HOSPITAL   (Canada)

^b DALHOUSIE UNIVERSITY   (Canada)

^c LERNER RESEARCH INSTITUTE   (United States)

^d MCGILL UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 10; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACTERIAL COUNT; CONTROLLED STUDY; DISEASE PREDISPOSITION; FEMALE; GENDER; GRAM NEGATIVE INFECTION; INFLAMMATION; KNOCKOUT MOUSE; LUNG INFECTION; MACROPHAGE; MALE; MOUSE; NONHUMAN; POLYMORPHONUCLEAR CELL; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; WEIGHT REDUCTION; WILD TYPE;

EID: 18744406665     PISSN: 00192805     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2567.2002.01508.x     Document Type: Article

References (50)

1. Wojnarowski C, Frischer T, Hofbauer E, Grabner C, Mosgoeller W, Eichler I, Ziesche R. Cytokine expression in bronchial biopsies of cystic fibrosis patients with and without acute exacerbation. Eur Respir J 1999; 14:1136-44.
2. Bonfield TL, Konstan MW, Burfeind P, Panuska JR, Hilliard JB, Berger M. Normal bronchial epithelial cells constitutively produce the anti-inflammatory cytokine interleukin-10, which is downregulated in cystic fibrosis. Am J Respir Cell Mol Biol 1995; 13:257-61.
3. Bonfield TL, Panuska JR, Konstan MW, Hilliard KA, Hilliard JB, Ghnaim H, Berger M. Inflammatory cytokines in cystic fibrosis lungs [published erratum appears in Am J Respir Crit Care Med 1996; 154: 1217]. Am J Respir Crit Care Med 1995; 152:2111-8.
4. Dosanjh AK, Elashoff D, Robbins RC. The bronchoalveolar lavage fluid of cystic fibrosis lung transplant recipients demonstrates increased interleukin-8 and elastase and decreased IL-10. J Interferon Cytokine Res 1998; 18:851-4.
5. Massengale AR, Quinn FJ, Yankaskas J, Weissman D, McClellan WT, Cuff C, Aronoff SC. Reduced interleukin-8 production by cystic fibrosis airway epithelial cells. Am J Respir Cell Mol Biol 1999; 20:1073-80.
6. Osika E, Cavaillon JM, Chadelat K, Boule M, Fitting C, Tournier G, Clement A. Distinct sputum cytokine profiles in cystic fibrosis and other chronic inflammatory airway disease. Eur Respir J 1999; 14:339-46.
7. Berger M. Inflammation in the lung in cystic fibrosis. A vicious cycle that does more harm than good? Clin Rev Allergy 1991; 9:119-42.
8. Bonfield TL, Konstan MW, Berger M. Altered respiratory epithelial cell cytokine production in cystic fibrosis. J Allergy Clin Immunol 1999; 104:72-8.
9. Noah TL, Black HR, Cheng PW, Wood RE, Leigh MW. Nasal and bronchoalveolar lavage fluid cytokines in early cystic fibrosis. J Infect Dis 1997; 175:638-47.
10. FitzSimmons SC. The changing epidemiology of cystic fibrosis. J Pediatr 1993; 122:1-9.
11. D'Agostino P, Milano S, Barbera C et al. Sex hormones modulate inflammatory mediators produced by macrophages. Ann N Y Acad Sci 1999; 876:426-9.
12. Miller L, Alley EW, Murphy WJ, Russell SW, Hunt JS. Progesterone inhibits inducible nitric oxide synthase gene expression and nitric oxide production in murine macrophages. J Leukoc Biol 1996; 59:442-50.
13. Bebo BF Jr, Schuster JC, Vandenbark AA, Offner H. Androgens alter the cytokine profile and reduce encephalitogenicity of myelin-reactive T cells. J Immunol 1999; 162:35-40.
14. Cutolo M, Sulli A, Seriolo B, Accardo S, Masi AT. Estrogens, the immune response and autoimmunity. Clin Exp Rheumatol 1995; 13:217-26.
15. Cutolo M, Accardo S, Villaggio B et al. Androgen and estrogen receptors are present in primary cultures of human synovial macrophages. J Clin Endocrinol Metab 1996; 81:820-7.
16. Djouadi F, Weinheimer CJ, Saffitz JE, Pitchford C, Bastin J, Gonzalez FJ, Kelly DP. A gender-related defect in lipid metabolism and glucose homeostasis in peroxisome proliferator-activated receptor alpha- deficient mice. J Clin Invest 1998; 102:1083-91.
17. Sawada M, Alkayed NJ, Goto S, Crain BJ, Traystman RJ, Shaivitz A, Nelson RJ, Hurn PD. Estrogen receptor antagonist ICI182,780 exacerbates ischemic injury in female mouse. J Cereb Blood Flow Metab 2000; 20:112-8.
18. Zuckerman SH, Bryan-Poole N, Evans GF, Short L, Glasebrook AL. In vivo modulation of murine serum tumour necrosis factor and interleukin-6 levels during endotoxemia by oestrogen agonists and antagonists. Immunology 1995; 86:18-24.
19. Moss RB, Hsu YP, Olds L. Cytokine dysregulation in activated cystic fibrosis (CF) peripheral lymphocytes. Clin Exp Immunol 2000; 25:518-25.
20. Angele MK, Knoferl MW, Schwacha MG, Ayala A, Cioffi WG, Bland KI, Chaudry IH. Sex steroids regulate pro- and anti-inflammatory cytokine release by macrophages after trauma-hemorrhage. Am J Physiol 1999; 277:C35-C42.
21. Kahlke V, Dohm C, Brotzmann K, Schreiber S, Schroder J. Gender-related therapy: Early IL-10 administration after hemorrhage restores immune function in males but not in females. Shock 2000; 14:354-9.
22. Wilder RL. Hormones, pregnancy, and autoimmune diseases. Ann N Y Acad Sci 1998; 840:45-5045-50.
23. Lalani I, Bhol K, Ahmed AR. Interleukin-10: Biology, role in inflammation and autoimmunity [published erratum appears in Ann Allergy Asthma Immunol 1998; 80:A-6]. Ann Allergy Asthma Immunol 1997; 79:469-83.
24. Moore KW, O'Garra A, de Waal M, Vieira P, Mosmann TR. Interleukin-10. Annu Rev Immunol 1993; 11:165-90.
25. Fiorentino DF, Zlotnik A, Mosmann TR, Howard M, O'Garra A. IL-10 inhibits cytokine production by activated macrophages. J Immunol 1991; 147:3815-22.
26. Bermudez LE, Champsi J. Infection with Mycobacterium avium induces production of interleukin-10 (IL-10), and administration of anti-IL-10 antibody is associated with enhanced resistance to infection in mice. Infect Immun 1993; 61:3093-7.
27. Greenberger MJ, Strieter RM, Kunkel SL, Danforth JM, Goodman RE, Standiford TJ. Neutralization of IL-10 increases survival in a murine model of Klebsiella pneumoniae. J Immunol 1995; 155:722-9.
28. Davidson NJ, Leach MW, Fort MM, Thompson-Snipes L, Kuhn R, Muller W, Berg DJ, Rennick DM. T helper cell 1-type CD4+ T cells, but not B cells, mediate colitis in interleukin 10-deficient mice. J Exp Med 1996; 184:241-51.
29. Standiford TJ, Strieter RM, Lukacs NW, Kunkel SL. Neutralization of IL-10 increases lethality in endotoxemia. Cooperative effects of macrophage inflammatory protein-2 and tumor necrosis factor. J Immunol 1995; 155:2222-9.
30. Gudmundsson G, Bosch A, Davidson BL, Berg DJ, Hunninghake GW. Interleukin-10 modulates the severity of hypersensitivity pneumonitis in mice. Am J Respir Cell Mol Biol 1998; 19:812-8.
31. Mallat Z, Besnard S, Duriez M et al. Protective role of interleukin-10 in atherosclerosis. Circ Res 1999; 85:e17-e24.
32. Yu H, Hanes M, Chrisp CE, Boucher JC, Deretic V. Microbial pathogenesis in cystic fibrosis. Pulmonary clearance of mucoid Pseudomonas aeruginosa and inflammation in a mouse model of repeated respiratory challenge. Infect Immun 1998; 66:280-8.
33. Sawa T, Corry DB, Gropper MA, Ohara M, Kurahashi K, Wiener-Kronish JP. IL-10 improves lung injury and survival in Pseudomonas aeruginosa pneumonia. J Immunol 1997; 159:2858-66.
34. Steinhauser ML, Hogaboam CM, Kunkel SL, Lukacs NW, Strieter RM, Standiford TJ. IL-10 is a major mediator of sepsis-induced impairment in lung antibacterial host defense. J Immunol 1999; 162:392-9.
35. Chmiel JF, Konstan MW, Knesebeck JE, Hilliard JB, Bonfield TL, Dawson DV, Berger M. IL-10 attenuates excessive inflammation in chronic pseudomonas infection in mice [in process citation]. Am J Respir Crit Care Med 1999; 160:2040-7.
36. Sapru K, Stotland PK, Stevenson MM. Quantitative and qualitative differences in bronchoalveolar inflammatory cells in Pseudomonas aeruginosa-resistant and -susceptible mice. Clin Exp Immunol 1999; 115:103-9.
37. Gosselin D, Stevenson MM, Cowley EA et al. Impaired ability of Cftr knockout mice to control lung infection with Pseudomonas aeruginosa. Am J Respir Crit Care Med 1998; 157:1253-62.
38. Gosselin D, DeSanctis J, Boule M, Skamene E, Matouk C, Radzioch D. Role of tumor necrosis factor alpha in innate resistance to mouse pulmonary infection with Pseudomonas aeruginosa. Infect Immun 1995; 63:3272-8.
39. Ishida H, Hastings R, Thompson-Snipes L, Howard M. Modified immunological status of anti-IL-10 treated mice. Cell Immunol 1993; 148:371-84.
40. Elborn JS, Cordon SM, Western PJ, Macdonald IA, Shale DJ. Tumour necrosis factor-alpha, resting energy expenditure and cachexia in cystic fibrosis. Clin Sci (Colch) 1993; 85:563-8.
41. Naon H, Hack S, Shelton MT, Gotthoffer RC, Gozal D. Resting energy expenditure. Evolution during antibiotic treatment for pulmonary exacerbation in cystic fibrosis. Chest 1993; 103:1819-25.
42. van Heeckeren AM, Tscheikuna J, Walenga RW, Konstan MW, Davis PB, Erokwu B, Haxhiu MA, Ferkol TW. Effect of Pseudomonas infection on weight loss, lung mechanics, and cytokines in mice. Am J Respir Crit Care Med 2000; 9:271-9.
43. Shepherd RW, Holt TL, Vasques-Velasquez L, Coward WA, Prentice A, Lucas A. Increased energy expenditure in young children with cystic fibrosis. Lancet 1988; 1:1300-3.
44. Shepherd RW, Holt TL, Cleghorn G, Ward LC, Isles A, Francis P. Short-term nutritional supplementation during management of pulmonary exacerbations in cystic fibrosis: A controlled study, including effects of protein turnover. Am J Clin Nutr 1988; 48:235-9.
45. Steinkamp G, Drommer A, von der Hardt H. Resting energy expenditure before and after treatment for Pseudomonas aeruginosa infection in patients with cystic fibrosis. Am J Clin Nutr 1993; 57:685-9.
46. Ward SA, Tomezsko JL, Holsclaw DS, Paolone AM. Energy expenditure and substrate utilization in adults with cystic fibrosis and diabetes mellitus. Am J Clin Nutr 1999; 69:913-9.
47. Konstan MW, Berger M. Current understanding of the inflammatory process in cystic fibrosis: Onset and etiology. Pediatr Pulmonol 1997; 24:137-42.
48. Armstrong L, Millar AB. Relative production of tumour necrosis factor alpha and interleukin 10 in adult respiratory distress syndrome. Thorax 1997; 52:442-6.
49. Kim HS, Armstrong D, Hamilton TA, Tebo JM. IL-10 suppresses LPS-induced KC mRNA expression via a translation-dependent decrease in mRNA stability. J Leukoc Biol 1998; 64:33-9.
50. Kishore R, Tebo JM, Kolosov M, Hamilton TA. Cutting edge. Clustered AU-rich elements are the target of IL-10- mediated mRNA destabilization in mouse macrophages. J Immunol 1999; 162:2457-61.